Here are relevant reports on : market-research
-
RNAI Technology Market- by Application (Research, Therapeutics) - Global Forecasts to 2019
The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Direct Conjugated Antibody Market by Application, Research Area, End User and Region - Global Forecast 2030
Direct conjugated antibodies are widely utilized in research and diagnosis, encompassing disciplines like immunology, cancer, and neuroscience. Direct conjugated antibodies are more in demand as a result of the increased prevalence of chronic diseases, rising R&D expenditures, and the requirement for precise diagnostics.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Legal AI Software Market by Offering (Legal AI Platforms, Generative AI Agents, Legal Drafting Tools, Report Generation Tools), Application (Ediscovery, Legal Research & Analytics, Contract Drafting & Review, IP Management) - Global Forecast to 2030
The legal AI software market is expected to grow from USD 3.11 billion in 2025 to USD 10.82 billion by the year 2030, at a CAGR of 28.3% during the forecast period. The major players in the legal AI software market include LexisNexis (US), Thomson Reuters (Canada), Sirion (US), Wolters Kluwer (Netherlands), Relativity (US), CS DISCO (US), and Consilio (US), along with SMEs and startups such as Harvey (US), vLex (US), Lawgeex (US), Neota Logic (US), and eBrevia (US).
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Nanoparticle Analysis Market by Technology (DLS, NTA, XRD, SMPS, CPC, NSAM), Analysis Type (Size, Zeta Potential, Weight, Flow properties), End-user (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions) - Global Forecast to 2020
This report studies the global nanoparticle analysis market over the forecast period of 2015 to 2020. The market is expected to reach USD 91.1 Million by 2020, at CAGR of 5.4% from 2015 to 2020. Rising focus on nanotechnology research, continuous advancements in nanoparticle analysis technologies, and increasing government spending on pharmaceutical R&D in emerging nations are key factors fuelling the growth of the nanoparticle analysis market. Increasing demand for customized medical implants, requirement of less sample volume and sample preparation in advanced analytical technologies, and stringent regulatory guidelines for drug approval are some other prime factors offering growth opportunities for players in the nanoparticle analysis market. However, high cost of nanoparticle analysis instruments is one of the key restraints for the market growth.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Thyroid Function Test Market by Type (TSH Tests, T4 Tests, T3 Tests), End User (Hospitals, Diagnostic Laboratories, Research Laboratories & Institutes), and Region (North America, Europe, APAC, LATAM, and MEA)
The global thyroid function test market is expected to grow at a CAGR of 5.9%. This growth can be attributed to factors such as increasing incidence of thyroid disorders, increasing awareness about thyroid disorders, increasing prevalence of lifestyle diseases, rising geriatric population, and increasing consumption of alcohol and tobacco. The prominent players in the global thyroid function tests market include Thermo Fisher (US), Abbott (US), Roche (Switzerland), DiaSorin (Italy), Danaher (US), Kronus (US), Merck (Germany), Cortez Diagnostics (US), bioMérieux (France), Qualigen (US), and Autobio Diagnostics (China).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Lab Accessories Market by Type (Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & Pharmaceutical Companies/Hospital/Private Labs/Research Institute) - Global Forecast to 2020
The laboratory accessories market is valued at $327.0 million in 2014. It is expected to reach $504.7 million by 2020, growing at a CAGR of 7.5% from 2014 to 2020. The laboratory accessories market is dominated by North America, it is followed by Europe, Asia and Rest of the world. The Asian market is the fastest growing in the forecast period (2014-2020). Reagent reservoirs is the fastest-growing segment of this market.
- Published: March 2015
- Price: $ 4950
- TOC Available:
-
Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecasts to 2023
The global gene panel market is expected to reach USD 2.95 Billion by 2023, at a CAGR of 19.2%. The growth of this market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panel owing to the benefits they offer. The gene panel market is fragmented, with the presence of several large as well as emerging players. Prominent players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, joint ventures, collaborations, and acquisition to widen their product portfolios and expand their presence in the market.
- Published: May 2018
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
